Christopher Stokoe
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 14
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 7
-
- Breast Cancer Treatment Studies 11
- Cancer Genomics and Diagnostics 2
- Co-authors
- Soonmyung Paik (2 shared papers)Priya Rastogi (2 shared papers)Jonathan Polikoff (2 shared papers)Norman Wolmark (2 shared papers)Louise Provencher (2 shared papers)Virginia F. Borges (2 shared papers)Charles E. Geyer (1 shared paper)Sandra M. Swain (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Cancer Research (4 papers)Clinical Breast Cancer (2 papers)Clinical Cancer Research (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Christopher Stokoe
17 papers receiving 537 citations
Peers
Comparison fields: 5 of 52
- Oncology 480
- Cancer Research 254
- Radiology, Nuclear Medicine and Imaging 189
- Pulmonary and Respiratory Medicine 134
- Genetics 38
Countries citing papers authored by Christopher Stokoe
This map shows the geographic impact of Christopher Stokoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Stokoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Stokoe more than expected).
Fields of papers citing papers by Christopher Stokoe
This network shows the impact of papers produced by Christopher Stokoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Stokoe. The network helps show where Christopher Stokoe may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Stokoe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 279 | |
| 2 | 2013 | 92 | |
| 3 | 2018 | 40 | |
| 4 | 2015 | 37 | |
| 5 | 2010 | 29 | |
| 6 | 2008 | 20 | |
| 7 | 2003 | 13 | |
| 8 | 2010 | 10 | |
| 9 | 2011 | 9 | |
| 10 | 2021 | 4 | |
| 11 | 2001 | 4 | |
| 12 | 2012 | 3 | |
| 13 | 2011 | 2 | |
| 14 | 2011 | 2 | |
| 15 | 2009 | 1 | |
| 16 | 2013 | 1 | |
| 17 | 2009 | 1 |
About Christopher Stokoe
Christopher Stokoe is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 17 papers that have together received 547 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (7 papers), Advanced Breast Cancer Therapies (3 papers), Lung Cancer Treatments and Mutations (2 papers), Cancer Genomics and Diagnostics (2 papers), Estrogen and related hormone effects (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Oncology (480 citations), Cancer Research (254 citations), Radiology, Nuclear Medicine and Imaging (189 citations), Pulmonary and Respiratory Medicine (134 citations) and Genetics (38 citations). Christopher Stokoe has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Soonmyung Paik, Priya Rastogi, Jonathan Polikoff, Norman Wolmark, Louise Provencher, Virginia F. Borges, Charles E. Geyer, Sandra M. Swain, Kathy S. Albain and Louis Fehrenbacher. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Breast Cancer, Clinical Cancer Research and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.